KANSL1L
geneOn this page
Also known as FLJ23861FLJ32349MSL1v2KIAA1267L
Summary
KANSL1L (KAT8 regulatory NSL complex subunit 1 like, HGNC:26310) is a protein-coding gene on chromosome 2q34, encoding KAT8 regulatory NSL complex subunit 1-like protein (A0AUZ9).
Predicted to enable histone acetyltransferase binding activity. Predicted to be located in intracellular membrane-bounded organelle. Predicted to be part of NSL complex.
Source: NCBI Gene 151050 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 156 total — 1 pathogenic
- MANE Select transcript:
NM_152519
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26310 |
| Approved symbol | KANSL1L |
| Name | KAT8 regulatory NSL complex subunit 1 like |
| Location | 2q34 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23861, FLJ32349, MSL1v2, KIAA1267L |
| Ensembl gene | ENSG00000144445 |
| Ensembl biotype | protein_coding |
| OMIM | 613833 |
| Entrez | 151050 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 13 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000281772, ENST00000415553, ENST00000418791, ENST00000428655, ENST00000429908, ENST00000438563, ENST00000452086, ENST00000453904, ENST00000457374, ENST00000460256, ENST00000634716, ENST00000867424, ENST00000867425, ENST00000867426, ENST00000867427, ENST00000967984, ENST00000967985
RefSeq mRNA: 2 — MANE Select: NM_152519
NM_001307976, NM_152519
CCDS: CCDS33370, CCDS77519
Canonical transcript exons
ENST00000281772 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000965169 | 210104104 | 210104301 |
| ENSE00001002835 | 210029803 | 210029918 |
| ENSE00001002840 | 210027296 | 210027350 |
| ENSE00001002842 | 210028845 | 210028969 |
| ENSE00001002843 | 210031421 | 210031546 |
| ENSE00001123725 | 210040420 | 210040527 |
| ENSE00001173078 | 210075552 | 210075756 |
| ENSE00001336989 | 210043939 | 210044104 |
| ENSE00001362522 | 210129031 | 210129172 |
| ENSE00001504502 | 210024033 | 210024201 |
| ENSE00001504503 | 210025104 | 210025216 |
| ENSE00001618187 | 210153495 | 210154611 |
| ENSE00001643572 | 210021421 | 210023179 |
| ENSE00001804956 | 210171149 | 210171409 |
| ENSE00003503204 | 210098086 | 210098207 |
Expression profiles
Bgee: expression breadth ubiquitous, 267 present calls, max score 95.65.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.7382 / max 110.0044, expressed in 1646 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 33457 | 4.8852 | 1528 |
| 33458 | 1.1634 | 637 |
| 33456 | 0.6896 | 314 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 95.65 | gold quality |
| nerve | UBERON:0001021 | 92.61 | gold quality |
| tibial nerve | UBERON:0001323 | 92.61 | gold quality |
| popliteal artery | UBERON:0002250 | 92.30 | gold quality |
| tibial artery | UBERON:0007610 | 92.29 | gold quality |
| adrenal tissue | UBERON:0018303 | 91.94 | gold quality |
| sural nerve | UBERON:0015488 | 91.71 | gold quality |
| left ovary | UBERON:0002119 | 91.12 | gold quality |
| aorta | UBERON:0000947 | 90.85 | gold quality |
| right ovary | UBERON:0002118 | 90.46 | gold quality |
| right lung | UBERON:0002167 | 90.27 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 90.17 | gold quality |
| right uterine tube | UBERON:0001302 | 89.70 | gold quality |
| endocervix | UBERON:0000458 | 89.68 | gold quality |
| metanephros cortex | UBERON:0010533 | 89.33 | gold quality |
| thoracic aorta | UBERON:0001515 | 89.26 | gold quality |
| ascending aorta | UBERON:0001496 | 89.22 | gold quality |
| body of pancreas | UBERON:0001150 | 89.19 | gold quality |
| ovary | UBERON:0000992 | 89.18 | gold quality |
| left coronary artery | UBERON:0001626 | 89.13 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 88.97 | gold quality |
| bronchial epithelial cell | CL:0002328 | 88.90 | gold quality |
| right coronary artery | UBERON:0001625 | 88.90 | gold quality |
| gall bladder | UBERON:0002110 | 88.80 | gold quality |
| ventricular zone | UBERON:0003053 | 88.62 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 88.55 | gold quality |
| thyroid gland | UBERON:0002046 | 88.48 | gold quality |
| body of uterus | UBERON:0009853 | 88.24 | gold quality |
| mucosa of stomach | UBERON:0001199 | 88.03 | gold quality |
| ectocervix | UBERON:0012249 | 87.74 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.32 |
| E-MTAB-6386 | no | 35.50 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
140 targeting KANSL1L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-6755-5P | 99.95 | 65.59 | 464 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-4525 | 99.94 | 64.38 | 675 |
| HSA-MIR-5010-5P | 99.94 | 64.11 | 705 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | kansl1l | ENSDARG00000075284 |
| mus_musculus | Kansl1l | ENSMUSG00000026004 |
| rattus_norvegicus | Kansl1l | ENSRNOG00000028149 |
| drosophila_melanogaster | nsl1 | FBGN0262527 |
Paralogs (1): KANSL1 (ENSG00000120071)
Protein
Protein identifiers
KAT8 regulatory NSL complex subunit 1-like protein — A0AUZ9 (reviewed: A0AUZ9)
Alternative names: MSL1v2
All UniProt accessions (5): A0AUZ9, A0A0U1RR24, H7BZ78, H7C1T2, H7C2S5
UniProt curated annotations — full annotation on UniProt →
Post-translational modifications. Acetylated on lysine residues by KAT8 upon ionizing radiation-induced DNA damage; deacetylated by HDAC3.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A0AUZ9-1 | 1 | yes |
| A0AUZ9-2 | 2 | |
| A0AUZ9-3 | 3 | |
| A0AUZ9-4 | 4 |
RefSeq proteins (2): NP_001294905, NP_689732* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026180 | NSL1 | Family |
| IPR029332 | PEHE_dom | Domain |
Pfam: PF15275
UniProt features (22 total): sequence conflict 8, splice variant 5, region of interest 2, compositionally biased region 2, modified residue 2, chain 1, domain 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0AUZ9-F1 | 50.48 | 0.07 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 462, 859, 134
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 175 (showing top):
CREL_01, TGCGCANK_UNKNOWN, GCANCTGNY_MYOD_Q6, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, SP1_Q2_01, MYCMAX_01, BASAKI_YBX1_TARGETS_DN, ZHANG_BREAST_CANCER_PROGENITORS_UP, BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP, OCT1_B, YNGTTNNNATT_UNKNOWN, GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX, GOCC_TRANSFERASE_COMPLEX, YGCGYRCGC_UNKNOWN, AHR_Q5
GO Biological Process (0):
GO Molecular Function (1): histone acetyltransferase binding (GO:0035035)
GO Cellular Component (3): NSL complex (GO:0044545), histone acetyltransferase complex (GO:0000123), H4 histone acetyltransferase complex (GO:1902562)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| enzyme binding | 1 |
| H4 histone acetyltransferase complex | 1 |
| chromatin | 1 |
| protein acetyltransferase complex | 1 |
| histone acetyltransferase complex | 1 |
Protein interactions and networks
STRING
604 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KANSL1L | OR7G2 | Q8NG99 | 513 |
| KANSL1L | LANCL1 | O43813 | 500 |
| KANSL1L | KAT8 | Q9H7Z6 | 469 |
| KANSL1L | EP400 | Q96L91 | 437 |
| KANSL1L | MYL1 | P05976 | 436 |
| KANSL1L | ADAM11 | O75078 | 427 |
| KANSL1L | ADAM23 | O75077 | 411 |
| KANSL1L | NUP210L | Q5VU65 | 409 |
| KANSL1L | MB21D2 | Q8IYB1 | 397 |
| KANSL1L | KANSL3 | Q9P2N6 | 388 |
| KANSL1L | ZNF736 | B4DX44 | 380 |
| KANSL1L | CSRNP3 | Q8WYN3 | 379 |
| KANSL1L | MYL4 | P11783 | 369 |
| KANSL1L | ZNG1E | Q5RIA9 | 359 |
| KANSL1L | ZNG1F | Q4V339 | 357 |
| KANSL1L | ZNG1C | Q5JTY5 | 357 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PHF20L1 | KANSL1L | psi-mi:“MI:0914”(association) | 0.350 |
| MAGEA10 | KANSL1L | psi-mi:“MI:0914”(association) | 0.350 |
| EXOC1 | KANSL1L | psi-mi:“MI:0915”(physical association) | 0.000 |
| KANSL1L | OPTN | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): KANSL1L (Two-hybrid), KANSL1L (Affinity Capture-MS), KANSL1L (Protein-peptide), KANSL1L (Cross-Linking-MS (XL-MS)), BCLAF1 (Cross-Linking-MS (XL-MS)), KANSL1L (Affinity Capture-RNA)
ESM2 similar proteins: A0AUZ9, A0JMF7, A1L2Y1, A3KMW7, A8MT70, A8MW92, A9JRX0, B0CM36, B0S6S9, B7ZS37, D3Z987, F1QB81, O95447, P40649, Q0IHW6, Q0P5X5, Q14B48, Q15468, Q3U285, Q3V089, Q49A88, Q4R815, Q4V9H5, Q5CZC0, Q5DTI6, Q5REF4, Q5T1N1, Q5ZJK5, Q66H35, Q6NRH7, Q6NRK3, Q6ZRS4, Q6ZU52, Q80VP2, Q80WQ8, Q8BLG0, Q8CB14, Q8CCJ9, Q8IUR6, Q8IX21
Diamond homologs: A0AUZ9, Q0IHW6, Q5DTI6, Q80TG1, Q7Z3B3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
156 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 128 |
| Likely benign | 5 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2427041 | NC_000002.11:g.(?210636797)(213403254_?)del | Pathogenic |
SpliceAI
3415 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:210023180:C:CC | acceptor_gain | 1.0000 |
| 2:210024028:CTTA:C | donor_loss | 1.0000 |
| 2:210024029:TTAC:T | donor_loss | 1.0000 |
| 2:210024030:TA:T | donor_loss | 1.0000 |
| 2:210024031:A:AC | donor_gain | 1.0000 |
| 2:210024031:AC:A | donor_gain | 1.0000 |
| 2:210024031:ACCTT:A | donor_loss | 1.0000 |
| 2:210024032:C:CG | donor_gain | 1.0000 |
| 2:210024032:CC:C | donor_gain | 1.0000 |
| 2:210024197:AAGCT:A | acceptor_gain | 1.0000 |
| 2:210024198:AGCT:A | acceptor_gain | 1.0000 |
| 2:210024200:CT:C | acceptor_gain | 1.0000 |
| 2:210024201:TC:T | acceptor_loss | 1.0000 |
| 2:210024202:C:CC | acceptor_gain | 1.0000 |
| 2:210024215:C:CT | acceptor_gain | 1.0000 |
| 2:210024216:A:T | acceptor_gain | 1.0000 |
| 2:210027289:AGCTT:A | donor_loss | 1.0000 |
| 2:210027290:GCTTA:G | donor_loss | 1.0000 |
| 2:210027291:CTTA:C | donor_loss | 1.0000 |
| 2:210027292:TTA:T | donor_loss | 1.0000 |
| 2:210027293:TACC:T | donor_loss | 1.0000 |
| 2:210027294:A:AC | donor_gain | 1.0000 |
| 2:210027294:ACCTC:A | donor_loss | 1.0000 |
| 2:210027295:C:CC | donor_gain | 1.0000 |
| 2:210027295:C:G | donor_loss | 1.0000 |
| 2:210027295:CCT:C | donor_gain | 1.0000 |
| 2:210027351:C:CC | acceptor_gain | 1.0000 |
| 2:210028841:ATACC:A | donor_loss | 1.0000 |
| 2:210028842:TAC:T | donor_loss | 1.0000 |
| 2:210028843:A:AC | donor_gain | 1.0000 |
AlphaMissense
6524 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:210098197:A:G | L480S | 0.999 |
| 2:210129107:A:G | L385P | 0.998 |
| 2:210129117:A:G | W382R | 0.998 |
| 2:210129117:A:T | W382R | 0.998 |
| 2:210027349:A:G | W800R | 0.997 |
| 2:210027349:A:T | W800R | 0.997 |
| 2:210129086:A:G | L392P | 0.997 |
| 2:210028862:C:A | K793N | 0.996 |
| 2:210028862:C:G | K793N | 0.996 |
| 2:210104123:A:G | L470P | 0.996 |
| 2:210129065:A:G | L399P | 0.996 |
| 2:210028911:A:G | I777T | 0.995 |
| 2:210104126:A:G | L469P | 0.995 |
| 2:210129135:C:G | A376P | 0.995 |
| 2:210104137:G:C | S465R | 0.994 |
| 2:210104137:G:T | S465R | 0.994 |
| 2:210104139:T:G | S465R | 0.994 |
| 2:210129102:C:G | A387P | 0.994 |
| 2:210028857:A:T | I795K | 0.993 |
| 2:210028917:A:C | I775S | 0.993 |
| 2:210098205:A:C | S477R | 0.993 |
| 2:210098205:A:T | S477R | 0.993 |
| 2:210098207:T:G | S477R | 0.993 |
| 2:210153871:C:G | A238P | 0.993 |
| 2:210027347:C:A | W800C | 0.992 |
| 2:210027347:C:G | W800C | 0.992 |
| 2:210028857:A:G | I795T | 0.992 |
| 2:210028867:A:G | Y792H | 0.992 |
| 2:210028917:A:T | I775N | 0.992 |
| 2:210075628:G:T | A560D | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000005896 (2:210085716 T>C), RS1000020421 (2:210026817 C>T), RS1000021835 (2:210172320 G>A), RS1000023764 (2:210034668 G>A), RS1000038238 (2:210167965 T>C), RS1000039442 (2:210130859 T>C), RS1000059840 (2:210085481 T>A), RS1000070758 (2:210168246 T>C,G), RS1000105602 (2:210121762 G>A,T), RS1000118797 (2:210078689 G>A), RS1000153363 (2:210139561 C>A), RS1000169193 (2:210078443 A>C), RS1000171683 (2:210051820 G>A), RS1000182901 (2:210140703 T>C), RS1000209950 (2:210149702 C>T)
Disease associations
OMIM: gene MIM:613833 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006249_98 | Serum metabolite levels | 2.000000e-24 |
| GCST006249_99 | Serum metabolite levels | 3.000000e-33 |
| GCST011053_7 | Neuroblastoma (pediatric) | 2.000000e-16 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, decreases methylation, affects expression | 7 |
| bisphenol A | increases expression, increases methylation | 2 |
| sodium arsenite | affects expression, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| entinostat | decreases expression | 1 |
| belinostat | decreases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Coal | decreases expression, increases abundance | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | decreases expression, increases reaction | 1 |
| Formaldehyde | decreases expression | 1 |
| Progesterone | increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Thimerosal | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): neuroblastoma